Come up with a name for your new list and we'll add to it:
GeNO raised a round of funding on October 18, 2013. Investors include
SFW Capital Partners.
GeNO is a privately-held biopharmaceutical company focused on the design, development and commercialization of next-generation products to address unmet medical needs of patients with a variety of pul…